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ABSTRACT
ROLE OF INDUCIBLE NITRIC OXIDE SYNTHASE AND P-SELECTIN
IN PLATELET-ARTERIOLAR WALL ADHESION AND ASSOCIATED
ARTERIOLAR CONSTRICTION DURING LUNG REPERFUSION

Alexander V. Ovechkin
February, 2005

Reperfusion of the ischemic lung causes pulmonary arteriolar vasoconstriction
and reduces alveolar perfusion. Lung ischemia-reperfusion (IR) injury leads to
platelet and leukocyte activation which could contribute to decreased alveolar
perfusion during reperfusion by platelet-arteriolar wall interactions (rolling and
adhesion) and subsequent microvascular constriction. During the oxidative stress of
ischemia and reperfusion, formation of reactive nitrogen species (RNS) may promote
platelet adhesion to the vascular wall with subsequent formation of microthrombi and
release of vasoactive substances. Platelets play an important role in causing
reperfusion injury in the systemic vasculature through accumulation and release of
mediators, but information is lacking about consequences of their interactions with
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the arteriolar wall in the pulmonary microcirculation over the time course of lung
reperfusion. During IR induced oxidative stress, overproduction of nitric oxide (NO)
could contribute to formation of harmful RNS by interactions with oxygen radicals.
The emphasis of the present study was to investigate the relationship between
inducible nitric oxide synthase (iNOS), RNS, P-selectin and platelet-arteriolar wall
rolling/adhesion and microvascular constriction in the intact lung during the time
course of pulmonary ischemia-reperfusion injury.
We examined the hypothesis that pulmonary IR induces platelet-arteriolar
wall rolling and adhesion (interactions) via a P-selectin dependent mechanism that
contributes to pulmonary microvascular constriction during reperfusion. Increased
P-selectin expression results from elevated iNOS activity and subsequent RNS
generation. Subpleural arterioles, labeled platelets, and leukocytes were examined
in anesthetized, open-chest rabbits by intravital fluorescence microscopy. Ischemia
was caused by reversibly occluding the right pulmonary artery for 5 min, 1 h or 2
h (5minIR group, lIR group and 2IR group, respectively).
During reperfusion, postischemic platelet rolling and adhesion were
independent from leukocyte-arteriolar wall interactions and correlated with pulmonary
arteriolar constriction in proportion to the length of ischemia. After l-h occlusion
during reperfusion, platelet rolling was significantly greater than in the 5minIR or
control group. Although arteriolar diameters decreased during the first 0.5 h of
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reperfusion, platelet adhesion was not increased and arteriolar diameters returned to the
baseline by 1 h of reperfusion. However, after two hours of ischemia, platelet rolling
increased and platelet adhesion was accompanied by arteriolar constriction that was
correlated with the level of platelet adhesion after both I-h and 2-h ischemia. Blockade
of systemic P-selectin by Fucoidan (the selectin ligand) inhibited platelet rolling,
adherence, and vasoconstriction. Pretreatment of only exogenously labeled platelets
with monoclonal antibody (MoAb) to P-selectin prevented platelet rolling and
adherence, but not vasoconstriction. In rabbits that were treated with an iNOS inhibitor
(1400W) before occlusion (2IR+ 1400W group), platelet-arteriolar wall interactions and
vasoconstriction were prevented. In lung tissue subjected to IR, iNOS activity and
expression were markedly greater than control and were also dependent on ischemia
duration. Immunochemically detected P-selectin and nitrotyrosine expression in
ischemic lung tissue, and the plasma level of soluble P-selectin in lIR and 2IR groups,
were significantly higher than in non-ischemic lungs and were inhibited by
pretreatment with 1400W.
These results indicate that during reperfusion of the intact lung, pulmonary IR
causes platelet rolling and adhesion along arteriolar walls and suggest that this
process is mediated by platelet and endothelial P-selectin. The results show that
platelet adhesion and arteriolar constriction during early reperfusion can result from
increased iNOS activity and is highly correlated with RNS and P-selectin expression.
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CHAPTER I

INTRODUCTION

Pulmonary ischemia-reperfusion (IR) injury may result from trauma,
atherosclerosis, pulmonary embolism, pulmonary thrombosis and surgical
procedures such as cardiopulmonary bypass and lung transplantation (152).
These conditions are associated with respiratory distress syndrome which is a
form of acute lung injury where there is a significant inflammatory response, as
well as extravascular fibrin deposition and thrombosis (147). During IR, injury
elicited by ischemia is amplified by incomplete restoration of blood flow due to
postischemic vasoconstriction and ventilation/perfusion mismatch (29,48).
High morbidity and mortality associated with IR, and complications
induced by IR, require further research to understand the pathophysiological
mechanisms of pulmonary IR injury. In view of the problem relating to alveolar
perfusion, elucidation of mechanisms of microvascular responses at the alveolar
level will improve the effectiveness of therapy for IR injury (112,147).
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PULMONARY IR INJURY

Lung IR leads to post-ischemic vasoconstriction (13,29) and significant
dysfunction of vasodilator and vasoconstrictor mechanisms (25,26,51,70).
Vascular abnormalities may include pulmonary hypertension, altered vascular
reactivity, vascular obstruction, intrapulmonary shunting, increased vascular
permeability

(pulmonary

edema),

and

ventilation/perfusion

mismatch

(48,13,150). In IR, the vascular response appears to occur in at least two
phases: 1) ischemia, which is associated with lack of oxygen, cell damage,
and activation of cytotoxic enzymes, and 2) reperfusion, which is associated
with formation of reactive oxygen intermediates, platelet and neutrophil
activation, endothelial cell injury, increased vascular permeability, cytokine
activity and complement activation (15,43). During the ischemic phase of IR
injury, when oxygen, ATP and other high-energy phosphates are depleted,
conversion from aerobic to anaerobic cellular metabolism causes formation of
cytotoxic metabolites (7,135,136). With re-establishment of perfusion, the
injury elicited by reperfusion can be more severe than that caused by ischemia
per se (43). The dysfunction of ATP-dependent enzymes affects ion transport
systems, causing accumulation of intracellular calcium. This cytosolic calcium
leads to activation of several calcium sensitive-enzymes, such as phospholipases,
with degradation of the membrane phospholipids (182). Nevertheless, it has been
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suggested that tissue injury mainly occurs during reperfusion (49), leading to the
formation of reactive oxygen species (ROS): superoxide anion, hydrogen
peroxide, and hypochlorous acid (71). The importance of oxygen radicals in the
pathophysiologic process of IR injury was demonstrated when injection of free
radical scavengers or enzymes, such as superoxide dismutase, catalase or
glutathione peroxidase, prevented damage

occurring during reperfusion

(50,54,180). The incomplete restoration of blood flow during reperfusion may
amplify the injury by prolonging "no-reflow" ischemia (13) due to post-ischemic
vasoconstriction (150). Pulmonary IR injury is different from IR in other systemic
vascular beds where oxygen is re-introduced during reperfusion. In the ventilated,
but non-perfused lung, although there is a small oxygen gradient which limits the
diffusion, the alveolar wall can be directly oxygenated before reperfusion (148,149).
In the lung, as in other tissues, ischemic and reperfusion damage can be identified
separately, and are not simply caused by endothelial cell dysfunction due to lack of
oxygen (148). Therefore, this suggests that the IR injury requires both ischemia and
reperfusion (39,149).

MICROVASCULAR EFFECTS OF PULMONARY IR

Post-ischemic lung perfusion is characterized by progressive microvascular
obstruction associated with formation of thrombi and vasoconstriction (15,43).
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Hypoxia can induce endothelial cells and macrophages to develop pro coagulant
properties, which may contribute to the formation of microvascular thrombosis and
compromise blood flow during reperfusion (108). Clinical and experimental studies
have shown that IR induces a rapid release of thrombin and proinflammatory
cytokines such as tumor necrosis factor alpha (TNFu), interleukin 1beta (lL-1 B), IL6, IL-9 and IL-10 which are potent cell activators and promoters of vasoactive
mediators (6,42,109,110,179). Proinflammatory cytokines participate in ischemiareperfusion injury of the heart, kidney, small bowel, skin, and liver, but little is
known about their roles in pulmonary IR injury (143). Cytokines modulate vascular
smooth muscle tone and modify the inflammatory response by regulating the
expression of adhesion molecules (15,47,163). This process leads to platelet- and
leukocyte-endothelial adhesion and formation of obstructive microembolic debris in
the capillary network (32,46,70,152). In addition, activated and adhered platelets
and leukocytes can release mediators such as serotonin, thromboxane Al, and
platelet activating factor, which contribute to vasoconstriction and edema formation
(11,14,113).

ROLE OF LEUKOCYTES AND PLATELETS IN PULMONARY IR

Leukocyte-endothelial cell adhesion and activation are implicated in
microvascular

dysfunction

associated

4

with

IR

III

different

tissues

(4,137,138,151), but their role in reperfusion injury is not yet clear (180). Several
studies demonstrated a role of leukocytes in the process of IR lung injury (10).
Others, however (3,8,40,140,181), observed tissue damage in the absence of
leukocytes and concluded that neutrophils did not participate in the damage
during ischemia and reperfusion. Neutrophil depletion in rats failed to prevent or
decrease lung injury that was caused by clamping the bronchus, pulmonary artery
and vein for 90 or 180 min before reperfusion (182). On further analysis, it
appears that there is a bimodal pattern of IR injury, consisting of an early
neutrophil-independent and a later neutrophil-mediated increase in microvascular
permeability (10,21,30,86).
During reperfusion, platelets have a very important role in post-ischemic
systemic hypoperfusion (18,20,25,32,164). Although, platelet activation and
accumulation are implicated in causing reperfusion injury in tissues such as
intestine, liver, pancreas, brain, and kidney (45,25,43), information is lacking
about their response and involvement over the time-course of reperfusion in the
ischemic lung (9). Okada et al found that accumulation of platelets in preserved
and subsequently reperfused rat lungs, correlated with the degree of reperfusion
injury in a lung transplant model (32). Platelet accumulation significantly
correlated with capillary congestion, suggesting that platelets contributed to the
lung injury, at least in part, by promoting hemostasis and forming micro-thrombi
(9,26,53,45,70). Platelets which are adhered to post-ischemic vascular
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endothelium, cause tissue damage by releasing free radicals and inflammatory
mediators, such as serotonin, leukotrienes and thromboxane A2 (81) which are
involved in post-ischemic leukocyte recruitment (12,82-84). Platelets have been
implicated early during the IR injury process, when formation of reactive oxygen
radicals, endothelial disruption, and release of cytokines promote their activation
and adhesion to the vascular wall (18,25,26). ROS can promote platelet activation
and cause up-regulation of the adhesion molecule, P-selectin, which is expressed on
the surface of platelets and endothelial cells (48,45,120) and can lead to plateletendothelial adhesion during pulmonary IR. Platelet activation and accumulation
could mediate IR injury through endothelial adhesion and thrombi formation, as
well as by interactions with leukocytes (77,124).

ROLE OF ADHESION MOLECULES IN PULMONARY IR

Adhesion molecules are divided into two major groups: selectins and
integrins. The current understanding is that selectins are responsible for initial
adhesive interactions and integrins are involved in subsequent firm platelet and
leukocyte adhesion to the endothelium and to each other (38,80,113). Platelet and
leukocyte adhesion both involve the sequential events of activation, rolling, and
firm adhesion. Rolling is dependent on selectin-mediated interaction between
endothelial cells (P-selectin and E-selectin), platelets (P-selectin) and leukocytes
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(L-selectin). Firm adherence and activation of leukocytes occurs when leukocyte
Bl-integrin or B2-integrin binds to endothelial cells expressing intercellular
adhesion molecule-I, or vascular endothelial adhesion molecule-I, respectively
(19,89,44,51). Blockade of adhesion molecules such as E-selectin, P-selectin,
intercellular adhesion molecule-I, and CD 18 during reperfusion, can reduce lung
reperfusion injury (79,98-102). L-selectin blockade may also be beneficial for
prevention of leukocyte adhesion after several hours of reperfusion when
neutrophils have a predominant role (99,103,104). When given before reperfusion,
analogs of the oligosaccharides, potent ligands for selectin adhesion molecules,
have also been shown to reduce IR injury (89,105-107).
Over-expression of selectins is a major cause of platelet-endothelial cell
adherence (2,5). P-selectin (CD62P, granule membrane protein 140 or plateletdependent granule or external membrane protein), the largest of the selectins with a
mass of 140 kDa, is constitutively expressed in the a-granules platelets (169) and
the Weibel-Palade bodies of endothelial cells (170). P-selectin is a membrane
protein with an N-terminallectin domain followed by an epidermal growth factor
motif, nine regulatory protein repeats, a transmembrane section and a short
intracytoplasmic C-tail (113,114,168). P-selectin is trans-located to the surface of
platelets and endothelial cells within minutes when these cells are activated by
stimuli such as thrombin, histamine, hydrogen peroxide or hypoxia (36,52,113). As
rapidly as two minutes after stimulation, P-selectin is expressed at the surface, but
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this expression can be short lived, reaching its peak after only 10 minutes and
declining to baseline after 3 hours (115-117). Additional synthesis of P-selectin is
brought about within 2 hours by different stimuli such as cytokines, tumor necrosis
factor-a, thrombin or oxygen radicals (116-118). Following platelet stimulation, Pselectin expressed on the platelet surface, becomes rapidly shed and forms the
soluble fraction of plasma P-selectin (171), which may have its own physiological
activity (28,168). In contrast, P-selectin expressed on the surface of the endothelial
cells does not contribute to the soluble P-selectin fraction (172).
The primary ligand for P-selectin is P-selectin glycoprotein ligand (PSGL-l), a
homodimeric mucin rich in 0- and N-glycans consisting of two 120 kDa polypeptide
chains, which is constitutively expressed mostly on endothelial cell and leukocyte
membranes (173) (Fig. 2). PSGL-l is a non-specific ligand and also acts as a ligand
for the other selectins (175). From P-selectin-PSGL-l interactions, multiple
downstream signaling events are generated involving their cytoplasmic tails. These
events include intracellular signaling with tyrosine phosphorylation of cytoplasmic
proteins (174) that triggers a functional upregulation of the integrins (CD11b/CDI8,
Mac-I) which mediates firm adhesion of platelets and leukocytes (168).
Physiological intravascular shear stress,

which causes a normal

concentration of NO, is an inhibitory regulator of P-selectin expreSSIOn
(119,120). P-selectin expression on activated platelets may not simply aid
platelet-endothelial adhesion and also may be important for inter-platelet
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aggregation (121,158). It has been suggested that P-selectin plays a role in
inflammation and atherogenesis by further activating the endothelium and
regulating production of platelet activating factor by monocytes (122), and
inducing the formation of tissue factor (123,124).
E-selectin occurs on endothelial cells after activation by inflammatory
cytokines and typically takes hours to express (34). Expression of P-selectin
appears to be involved in myocardial IR injury, where it may cause early
reperfusion-induced tissue damage attributed to neutrophil infiltration (33).
Cooper D. et al (45) found that IR induces time-dependent platelet-endothelial
adhesion in postcapillary venules via a mechanism that involves both platelet and
endothelial P-selectin, with platelet P-selectin playing a greater role.
Recent studies suggest that platelets are important in IR injury, not only
through adhesion and thrombi formation, but also through participation in
inflammatory interactions with leukocytes (77). IR leads to an inflammation
reaction by leukocyte infiltration and subsequent organ dysfunction (74,75).
Activated platelets contribute to leukocyte adhesion to the vascular wall enabling
them to transfer to the surface of the endothelium (76,77). Moreover, Nishijima
et al (2004) demonstrated in vivo that platelet depletion suppresses leukocyte
rolling and accumulation in post-ischemic tissues. They showed that platelets
playa major role in the leukocyte recruitment after ischemia-reperfusion through
expression of platelet P-selectin (73).
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IR INDUCED OXIDATIVE STRESS

IR causes oxidative stress which is characterized by the formation of
superoxide anion, hydrogen peroxide and hydroxyl radicals, collectively known
as reactive oxygen species (ROS) (89,90). Pulmonary endothelial cells, smooth
muscle cells, and lung macrophages have all been shown to generate superoxide,
under both basal and stimulated conditions (95,96,129-131). The endothelial cell
content of superoxide is also modulated by mechanical forces such as
physiological shear stress which was found to reduce superoxide (132,177).
During ischemia, the absence of shear stress triggers endothelial cell membrane
depolarization which leads to activation of NADPH oxidase, nuclear factor-KB,
and iNOS (95,97).
ROS have diverse actions on pulmonary tissue, including smooth muscle
contraction, interaction with redox enzymes, cell proliferation, and gene
transcription (128,145). ROS produce endothelial cell injury by lipid
peroxidation of their membranes (90,139,144), and downregulate nitric oxide
(NO) released from the endothelium, thus compromising endothelium-dependent
relaxation (125,126). In addition, overproduction of superoxide antagonizes the
effects of a wide range of NO donors by reacting with NO (127). Mechanisms of
ROS formation include accumulation of hypoxanthine and conversion of the
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enzyme xanthine dehydrogenase into xanthine oxidase during hypoxia, with the
degradation of hypoxanthine into superoxide after reoxygenation (91). An
NADPH oxidase-dependent mechanism forms ROS by reduction of oxygen into
hydrogen peroxide and superoxide anion (92). IR of the ventilated lung has to be
considered differently from other tissues, if oxygen is present in the alveoli
during the ischemic period. On the one hand, alveolar oxygen helps maintain
aerobic metabolism and prevents hypoxic ROS formation (92,93). On the other
hand, the absence of blood flow with a low oxygen gradient in the lung tissue
and a high concentration of oxygen in the gas mixture can cause ROS formation
(91,94). Reactive oxygen metabolites can promote the formation of inflammatory
agents by lipid peroxidation and subsequently activate and recruit leukocytes to
post-ischemic tissue (43).
When NO reacts with ROS, it forms secondary reactive products such as
nitrosonium cation (NOl, nitroxil anion (NO) and peroxynitrite (ONOO-) (65,159)
known as reactive nitrogen species (RNS) (128,134). Peroxynitrite, the most
common form of RNS, has been suggested to be responsible for significant
cytotoxic effects and platelet activation (134). Reperfusion injury in skeletal muscle
tissue (141), and platelet activation in vitro (142), can be prevented by superoxide
free-radical scavengers (162). Following intestinal ischemia, increased iNOS
expression and NO overproduction caused pulmonary damage by nitrosylation of
tyrosine residues (88). Peroxynitrite reacts with most biological molecules, making
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peroxynitrite, a selective oxidant. Peroxynitrite modifies tyrosine in proteins to
create nitrotyrosine, which is a RNS footprint that has been detected in vivo in major
pathological conditions including IR (111,153).

ROLE OF NITRIC OXIDE IN PULMONARY IR

Nitric oxide has become a well known signaling molecule critical to
maintaining many physiological functions, including vascular tone. However, it
has been shown that NO can be both protective (61-63) and deleterious to
vascular homeostasis (64) through direct effects on cell signaling, as well as
indirect actions. Overproduction of NO via the inducible nitric oxide synthase
(iNOS) pathway is an important component in the pathogenesis of IR injury (5557,72). During IR, excess NO production has been attributed to iNOS that is not
stimulated under normal conditions, but can be induced within 2 h of lung
reperfusion (65) and results in upregulation of adhesion molecules (68). The direct
effects of NO are related to low and brief NO production. These effects are
usually involved in protective mechanisms such as arterial vasodilatation, which
leads to improved perfusion and oxygen delivery, and antithrombotic activity,
principally by inhibiting platelet function under normal physiologic conditions.
In contrast, indirect effects occur under high and sustained flux of NO under
pathophysiologic circumstances (65). Administration of NO during ischemia in a
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systemic vascular bed was reported to be protective in IR (87), but administration
of NO during reperfusion is associated with endothelial dysfunction and
increased vascular permeability (86). These pathological effects could relate to
the interaction of NO with reactive oxygen species, since they are prevented by
superoxide free radical scavengers (141,142). Physiological concentrations of
NO inhibit platelet activation by downregulating platelet P-selectin (31,157)
through activation of platelet soluble guanilate cyclase and increasing levels of
cGMP (161). A regulatory effect of NO on endothelial P-selectin expression that
modulates

leukocyte-endothelial

cell

interactions

to

preserve

vascular

homeostasis also has been shown (119).
NO is synthesized by nitric oxide synthase (NOS), a complex enzyme
which acts on a pair of substrates (molecular oxygen and L-arginine) to produce
NO and L-citrulline (58,155).

This process requires five essential cofactors

(FMNH z, FADH, NADPH, calmodulin and tetrahydrobiopterin) and two divalent
cations: Caz+ and heme Fez+. Three distinct isoforms of NOS have been
identified: neuronal NOS (nNOS or NOS 1), endothelial NOS (eNOS or NOS 3),
and inducible NOS (iNOS or NOS 2). All 3 known NOS isoforms are expressed
in the lung, including nNOS and eNOS, which are calcium-dependent and
usually expressed constitutively. However, iNOS is calcium-independent and is
expressed only when cells are stimulated (59,60,156).

The iNOS has been

implicated in the pathogenesis of IR injury, shock and inflammation (48,55-57).
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Following intestinal ischemia, Virlos et al (2003) (88) found that pulmonary
damage is associated with increased iNOS expression, NO overproduction and
consequent nitrosylation of protein tyrosine residues in the lung which leads to,
and aggravates pulmonary injury. Under stress, when cellular L-arginine is
depleted, NO synthase is capable of generating superoxide (133). In addition,
inhibition of physiological NO production leads to increased leukocyte (146) and
platelet (157,165) rolling and adhesion in various vascular beds, and adhesion
molecule P-selectin is implicated in these processes (146).
During IR, excess NO production has been attributed to iNOS that is not
present under normal conditions, but can be induced within 2 h, reaching significant
levels by 4 to 6 h oflung reperfusion (59,60). The iNOS inhibitor amino guanidine,
as we showed previously (167), attenuates increased pulmonary vascular resistance
during lung IR (184). The local release oflarge amounts of NO by iNOS is linked to
the production of harmful oxidative products such as peroxynitrite, when NO reacts
with other molecules such as superoxide (65-67). In experiments with "iNOS-knock
out" mice, Cuzzocrea S. et al (68) showed that that the induction of iNOS and NO
production are essential for the upregulation of the inflammatory response in
splanchnic IR. Both iNOS and NO participate in end-organ damage by upregulation
of adhesion molecules, neutrophil infiltration, as well as oxidative and nitrosative
stress. ROS, produced during IR, have also been implicated in a number of signal
transduction pathways (69). Normal concentrations of NO act as an inhibitory
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regulator of P-selectin expreSSIon (119), and inhibition of physiological NO
production leads to increased platelet and leukocyte rolling and adhesion in various
vascular beds (146,157). In contrast, high and sustained flux of NO under
pathophysiologic circumstances leads to increased P-selectin expression (65,119)
which may promote to platelet-vascular wall interactions.

SUMMARY

IR induces oxidative stress and is characterized by formation of ROS and
reactive nitrogen species. As a consequence of the oxidative stress, there are
platelet-endothelial interactions and release of vasoactive substances. IR induced
oxidative stress can up-regulate the adhesion molecule, P-selectin, which is
rapidly expressed on the surface of stimulated platelets and endothelial cells and
leads to platelet-arteriolar wall rolling and adhesion. These platelet-endothelial
interactions play an important role in causing post-ischemic hypoperfusion and
may contribute to the arteriolar vasoconstriction during reperfusion by releasing
mediators such as serotonin, thromboxane A2, and platelet activating factor and cause
further

endothelial

damage

associated

with

microvascular

hypoperfusion.

Overproduction of NO via the iNOS IS an important component in the
pathogenesis of ischemia-reperfusion injury. When NO reacts with ROS, it form
secondary reactive products known as reactive nitrogen species. Peroxynitrite is
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the most common form of RNS and has been suggested to be responsible for
significant cytotoxic effects, as well as platelet activation that may result in
upregulation of adhesion molecules. This mechanism of injury may be
particularly important during pulmonary IR with increased iNOS activity in the
presence of oxidative stress.

HYPOTHESIS AND SPECIFIC AIMS

Reperfusion

of the

ischemic

lung

causes

pulmonary arteriolar

vasoconstriction and reduces alveolar perfusion. During the oxidative stress of
ischemia and reperfusion, formation of reactive nitrogen species may promote
platelet adhesion to the vascular wall with subsequent formation of microthrombi
and release of vasoactive substances. Platelets play an important role in causing
reperfusion injury in the systemic vasculature. However, information is lacking
about consequences of their interactions with the arteriolar wall in the pulmonary
microcirculation over the time course of lung reperfusion. During IR induced
oxidative stress, overproduction of NO could contribute to formation of harmful
RNS. The emphasis of the present study was to investigate the relationship between
iNOS,

RNS,

P-selectin

and platelet-arteriolar wall

rolling/adhesion and

microvascular constriction in the intact lung during the time course of pulmonary
ischemia-reperfusion injury. The overall goal of this research was to investigate
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mechanisms causing increased platelet interaction with endothelium which could
lead to pulmonary arteriolar constriction and decreased alveolar blood flow. We
examined the hypothesis that pulmonary IR induces platelet-arteriolar wall
interactions via a P-selectin dependent mechanism and contributes to
pulmonary microvascular constriction during reperfusion. Increased Pselectin expression results from elevated iNOS activity and subsequent RNS
generation (Fig. 1).

The specific aims were:

l. To determine if platelet rolling and/or adhesion along pulmonary

arterioles occurs during lung reperfusion and, if so, could those
interactions

contribute

to

pulmonary

postischemic

microvascular

constriction.
2. To examine if platelet and/or lung tissue P-selectin is involved in plateletarteriolar wall interactions during pulmonary reperfusion.
3. To investigate if there is an increase in iNOS activity which leads to RNS
formation, and P-selectin dependent platelet-arteriolar wall interactions
during reperfusion.
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CHAPTER II

MATHERIALS AND METHODS

General. Approved by IACUC, experiments were done acutely on male rabbits
(2.2 ± 0.2 kg body weight) (178). Anesthesia was induced with a ketaminexylazine mixture (1 mllkg; containing ketamine 37.5 mg/ml and xylazine 5
mg/ml) given intramuscularly followed by aliquots of sodium pentobarbital (5
mg/kg) given slowly through an ear vein to gradually reach a loading dose of
approximately 40 mg/kg. A catheter (PE 90) was placed in the left femoral vein
for subsequent injections of supplemental doses of sodium pentobarbital
(approximately 6-10 mg/kg or 25 mg/h) to maintain an adequate level of
anesthesia as defined by absence of an active corneal reflex, whisker twitching,
and a pedal reflex to a toe pinch. Spontaneous breathing was suppressed at this
level of anesthesia. The trachea was cannulated below the larynx and the lungs
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were ventilated with air by a volume-cycled ventilator (CWE, model CTP-930,
Ardmore, PA) with 0-3 cm H20 positive end-expiratory pressure. Tracheal
pressure was measured through a sideport of the tracheal catheter that was
attached to a volumetric pressure transducer (Grass PT-5, Quincy, MA). Tidal
volume and frequency were adjusted as necessary to achieve normal blood gas
values during control. PE-90 was placed in the left femoral artery to monitor
arterial blood pressure by a transducer (Statham P23ID, Gould, Oxnard, CA) and
to periodically removing blood samples for P0 2, PC0 2, and pH measurements
(NOVA Biomedical, STAT Profile 1 analyzer, Waltham, MA). Catheter patency
was maintained by using 0.5-1.0 ml of heparinized (10 units/ml) 0.9% saline to
clear the catheter after obtaining blood samples (Fig.3). In all animals, after the
initial surgery, the lungs were ventilated with 50% O2 in N2 to keep arterial P02
above 100 mmHg during IR. Tidal CO 2 was monitored by a CO 2 analyzer
(Nellcore, model BP-I000, Haward, CA) and kept at about 40 mm Hg by
adjusting ventilation. PE 90 was placed in the right atrium via the right jugular
vein to inject rhodamine, fluorescently labeled platelets, and to infuse 1400W.
The signals representing tracheal pressure, arterial blood pressure, and heart rate
were amplified and recorded continuously by a polygraph system (Grass model
7D, Quincy MA).
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Microvascular Observations. With the rabbit on a temperature-controlled heating
pad on the stage of a modified trinocular microscope (Zeiss, Thornwood, NY)
equipped with epi-illumination, the chest was opened mid-sternally and the right
pulmonary artery was exposed at the hilum of the lung. The rabbit was placed on
its left side and the right side of the chest was opened in the fifth intercostal
space. The objective lens (Leitz LIO, numerical aperture 0.22) with a glass
dipping cone (5-mm diameter at the tip) was positioned above the right lung and
lowered to the pleural surface using a technique for observing subpleural vessels
and ventilated alveoli in the intact lung (37) when the lung was held inflated for
brief periods (about I min) by switching from the ventilator to a system that
delivered O2 at a constant pressure of approximately 10 cm H20. A lightsensitive silicon-intensified target (SIT) camera (C2400, Hamamatsu Photonics,
Japan) was used to transfer images to a high-resolution monitor that were stored
on videotape for off-line analysis (Fig.4). Arterioles were identified, and internal
vessel diameters and segment lengths were measured from the monitor screen with
a caliper that was calibrated using a stage micrometer. From images recorded
continuously during observation periods, measurements were made at 3-s intervals
over a period of 30 s. Between observations, the surface of the lung was kept moist
by spraying it with physiological saline solution kept at about 37°C.
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Pulmonary Artery Occlusion-Reperfusion. A removable surgical clip was placed on
the right main pulmonary artery to occlude pulmonary blood flow to the right lung
(ischemia) and then removed to initiate reperfusion. The effectiveness of occlusion
(and reperfusion) was verified by microvascular examination for the presence of
subpleural blood flow.

Fluorescent Labeling of Platelets, Platelet Counting and Analysis of their
Behavior. Blood (2.2 mllkg of body weight) was removed before pulmonary
artery occlusion from the femoral artery catheter with a syringe containing 3.2%
trisodium citrate (with a ratio of 1 part of citrate to 9 parts blood; final citrate
concentration, 10.9 mM) and centrifuged at 200 x g for 15 min. The platelet-rich
plasma was carefully collected from the centrifuge tubes with a fine-tip plastic
pipette, transferred to separate tubes, and centrifuged at 800 x g for 10 min. The
supernatant was discarded and the platelet pellet was resuspended in 3 ml of
calcium-free Tyrodes buffer (TBSS; composition in mM: NaCl, 137; KC1, 2.6;
NaH 2P04 , 0.4; MgClz, 1.0; and glucose, 5.6, pH

=

7.4) containing 10 mM

HEPES and 0.25% bovine serum albumin (24). The suspension was centrifuged
at 800 x g for 10 min, and then the platelet pellet was resuspended in I ml of
TBSS and 8 III BCECF, AM (2 1, 7 1-bis-(2-carboxyethyl)-5-[ and -6]carboxyfluorescein, acetoxymethyl ester (Molecular Probes, Inc., Eugene, OR).
The suspension was gently mixed and incubated for 15 min at 37°C with
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occasional gentle agitation. After incubation, the conjugate suspenSIOn was
centrifuged at 800 x g for 5 min to remove excess fluorescence. The
fluorescently labeled platelets were then resuspended in 1.0 ml of TBSS without
albumin. A 20-lll sample was used for platelet counting and examination in a
hemocytometer. An inverted microscope (Zeiss Axiovert 10, Germany) equipped
with a blue filter (450-490 nm) was used for platelet counting and to ensure that
platelets in the sample were labeled, and that there was an absence of platelet
aggregates. The remainder of the platelet suspension was drawn into a 1-ml
syringe for subsequent injection into the right jugular vein. In some experiments,
nonlabeled platelets were counted from arterial blood samples taken before
pulmonary artery occlusion and at the end of the experiment after 2 h of
reperfusion. The behavior of the labeled platelets in microvessels was detected
using a fluorescence filter (450-490 nm) on the light source (100 W mercury arc
lamp) of the microscope and the light-sensitive video camera using off-line,
frame-by- frame video analysis similar to methods reported by others (9).
Platelets were classified as free flowing, rolling, or adherent according to their
interaction with the endothelium. Free flowing platelets were those that passed an
imaginary line perpendicular to the vessel axis in the area of interest, without
apparent endothelial interaction. Adherent platelets were defined as those
platelets that did not detach from the endothelium for a period of at least 3 s.
Rolling platelets were defined as those platelets that moved along the

22

endothelium of the vessel, touching a visible wall. These platelets moved at a
much slower velocity than the platelets in the center of the vessel and even
stopped periodically (for less than 3 s). Platelet rolling was quantified as the
number of rolling platelets per square millimeter of vessel area during 30 s.
Platelet adherence was quantified as the average number of adherent platelets per
square millimeter of vessel area over 30 s. To control for differences in the
number of platelets flowing per time, for each measurement period, platelet
rolling and adherence were also normalized. The above values were divided by
the total number of platelets that could be observed entering the vessel segment
during the measurement interval (30 s) and expressed as a percent. Observations
were made in arterioles that were approximately one to two branching orders
upstream of the pulmonary capillaries (37), and platelets were counted along
relatively straight sections (on average, approximately 250

~m

long) between the

visible branches. Internal arteriolar diameter was taken as the average of
measurements at the proximal, middle, and distal end of the observed segment,
and the area of the vessel segment in the focal plane of the objective was
calculated. The same arteriolar segments were observed over the course of an
experiment, and length and diameter measurements were repeated for each 30-s
observation period.
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In Vivo Fluorescence Labeling of Leukocytes and Analysis. A rhodamine (60)
dye solution 0.2 ml/kg body weight) prepared by dissolving rhodamine in saline
(0.02g/l00ml) and used according the methods of Kuhnle et al (21), was injected
into jugular vein. Leukocyte flux in the vessel was quantified as the number of
leukocytes rolling or adhered per time unit. The observation period was 15-30
seconds. Leukocytes intermittently interacting with the vessel endothelium
(rolling cells) were identified as those cells moving considerably slower than
leukocytes in the center stream and making intermittent contact with the
endothelium. They were expressed as cells/endothelial area (calculated as
number of cells/length of observed vessel segment x vessel diameter).

Administration of Fucoidan, 1400W and Use of Monoclonal Antibodies to PSelectin. In experiments with the 2IR+Fucoidan group, Fucoidan (Sigma Co., St.
Louis, MO) was infused (27

~g/kg/min,

0.57 ml/h) into the right jugular vein

approximately 10 min before reperfusion was started. This dose of Fucoidan has
been shown to inhibit P- and L-selectins in similar types of experiments (33).
Infusion was continued throughout the reperfusion period. In another series of
experiments, to inhibit platelet P-selectin expression, a monoclonal anti-human
P-se1ectin antibody (CD-62P, 25

~g/ml)

we added to the fluorescently labeled

platelets before they were injected (2IR+MoAb group). Rabbit P-selectin has
been found to have a 74% homology with human P-selectin (36). For a control,
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in other rabbits, the same concentration of an isotype-matched nonblocking
antibody (IgG 1K) was added to the labeled platelets before injection (antibodies
were purchased from Ancell Corporation, Bayport, MN) (2IR+ IgG group). In
the 2IR+ 1400W group, approximately 10 minutes before the occlusion period
was started, an iNOS blocker (1400W, 10 mg/kg, 4.1 ml/h) was infused through
the right jugular vein catheter during 1 h prior to a 2-h occlusion (166).

Topical application of peroxynitrite to the subpleural arterioles. Sodium
peroxynitrite solutions were prepared according to manufacturer instructions
(Cayman chemical, Ann Arbor, MI). 0.5 or 1.0 JlM of peroxynitrite was applied
to subpleural arterioles in 100 Jll aliquot immediately after a control period
during microvascular observation. The vehicle control was done by replacing 0.5
and 1.0 JlM of peroxynitrite to O.3N NaOH (0.044 mM and 0.088 mM,
respectively) in saline.

Lung tissue samples. After 2-h reperfusion, both lungs from all animals were
perfused with 60 ml of ice-cold saline via the main pulmonary artery, removed
from the animal, frozen in liquid nitrogen, and stored at -80°C.

Western Blot Analysis For iNOS. After 2-h reperfusion, the lungs were perfused
with 60 ml of ice-cold saline via the main pulmonary artery, removed from the
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animal, frozen in liquid nitrogen, and stored at -80°C. Lung tissue was
homogenized on ice in a buffer containing Tris (25 mM), EDTA (10 mM),
EGTA (10 mM), NaF (10 mM), PMSF (100 mM), Aprotonin

(1 mg/ml),

Leupeptin (1 mg/ml), and 10% Triton-X. Homogenized lung samples were
sonicated on ice and centrifuged at 10,000 x g for 15 minutes. Cell membrane
and cytosolic fractions were separated by ultracentrifugation of the supernatant at
100,000 x g for 1 hour and the cytosolic fraction was used for Western blot
analysis of iNOS. Proteins (100 Jlg) were separated by SDS-PAGE on a 4-12%
gradient denaturing gel and electro-blotted onto nitrocellulose membranes. Gel
transfer efficiency and equal loading of proteins was verified by Ponceau
staining of nitrocellulose membranes. The membrane was blocked for 1 h in 5%
nonfat milk in Tris-buffered saline with Tween-20 (0.05%) (TBS-T) and
incubated overnight with a rabbit polyclonal anti-iNOS primary antibody
(Upstate; Lake Placid, NY; 1: 1000 dilution). The nitrocellulose membranes were
washed with TBS-T and then incubated with a horseradish peroxidase (HRP)conjugated anti-rabbit antibody (Cell Signaling Technologies; Beverly, MA), and
washed with TBS-T. Proteins were visualized by a standard chemiluminescence
(ECL) method (Amersham Biosciences). Equal loading of proteins was verified
by probing the membrane with a mouse monoclonal

anti-~-actin

primary

antibody (Sigma, 1:20,000 dilution). The films were scanned by an optical
scanner (UMAX Powerlook II, Dallas, TX) and quantified by measuring the
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density of each band and subtracting the background density using UN-SCAN-IT
software (Silk Scientific, Inc.; Orem, UT). To correct for possible unequal
loading, each band's optical density was normalized by its

~-actin

density.

NOS Activity Measurements were quantified by counting the radioactivity of the
eluate (citrulline) with a liquid scintillation counter using a NOS activity assay
kit (Cayman Chemical). Lung tissue (100 mg) was homogenized in a buffer
containing 250 mM Tris-HCL (PH 7.4),10 mM EDTA, and 10 mM EGTA and
centrifuged at 10,000 x g for 15 minutes at 4°C. Forty Ilg of protein from the
supernatant was incubated with a reaction buffer containing 50 mM Tris-HCI
(pH 7.4), 6 IlM tetrahydrobiopterin (BH4), 2 IlM flavin adenine dinucleotide, 2
IlM flavin adenine mononucleotide, and 14C or 3H arginine (1IlCi/lll) for 1 hr.

After incubation, the reaction was stopped with a buffer containing 50 IlM N-2hydroxyethylpiperazine-N' -2-ethanesulfonic acid (HEPES pH 5.5) and 5mM
EDTA. An equilibrated resin, which binds unreacted arginine, was added to the
reaction mixture and the entire solution was placed into spin cups to separate
arginine and citrulline. Activity was expressed as counts per minute (CPM)/40
Ilg protein. Positive and negative (no sample) controls were used to check

reaction efficiency and control for background readings respectively.
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Fluorescence Immunohistochemistry for lung tissue P-selectin and Nitrotyrosine
expression analysis. Sections (10 /-lm) were cut from snap-frozen tissue blocks,
air dried for 2 h, and fixed at room temperature (20-25°C) in acetone for 10 min.
After complete dehydration and removal of the media around tissue, slides were
washed in O.IM TBS for 5 min and blocked with 10% donkey serum in O.1M
TBS + 0.3% triton + 0.5% BSA solution for 1 h. Primary antibodies (mouse antiP-selectin CD62P or anti-Nitrotyrosine IgG J isotype, 1:200) in O.IM TBS + 0.3%
triton + 0.5% BSA + 5% serum were applied for 24 h at 4°C, followed by a 10
min rinse in O.1M TBS. After being washed in O.1M TBS (3 x 10 min), slides
were covered with fluorescently labeled secondary antibodies in O.1M TBS +
0.3% triton + 5% serum, and incubated in the dark at room temperature for 1 h.
The slides were washed the same way again, and covered using a Prolong
Antifade kit (Molecular Probe, Eugene, OR). A negative control was prepared by
replacing specific antibodies with non-specific IGg J antibodies. The expression
was detected on a fluorescent microscope (Nikon Eclipse E800) with 10xlO.30
Plan Fluor Objective and RT Color Spot Camera (Diagnostic Instruments Inc.,
Sterling Heights, MI). Five fields from every tissue section were randomly
selected using a UV-2A filter followed by switching to a FITC-HYQ filter.
Quantitative analysis was done using an Image Pro program (IMAGE-PRO
Media Cybernetics, Silver Spring, MD). Data were expressed in area (px2) of
marker and averaged for each group.
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Plasma sP-selectin concentration detection. Citrated plasma samples were taken
during baseline and after 2 h of reperfusion (85). Quantitative analysis of soluble
P-selectin (sP-selectin) was done using the ZyQuik sP-selectin enzyme-linked
immunosorbent sandwich assay (ELISA) Kit (Zymed Laboratories Inc., San
Francisco, CA) and SpectraMax M2 Analyzer (Molecular Device, Sunnyvale,
CA) according to the manufacturer's instructions. The data were expressed as sPselectin concentration in plasma (ng/ml).

EXPERIMENTAL DESIGN

The specific aim #1 was to determine if platelet rolling and/or adhesion along
pulmonary arterioles occurs during lung reperfusion and, if so, could those
interactions contribute to pulmonary postischemic microvascular constriction.
This aim was investigated by examining the effects of pulmonary artery ischemia
on platelet-/leukocyte-arteriolar wall interactions and vasoconstriction in
subpleural arterioles during the time course of pulmonary reperfusion. To
investigate the "dose response", the right pulmonary artery had been clipped for
different time periods. Animals with shorter occlusions (5 min) served as sham
controls and animals without occlusion were controls for animals where the right
pulmonary artery was clipped for 1 h or 2h. Subpleural arterioles in the right lung
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identified during a control period were subsequently observed over 30-s periods
during occlusion and reperfusion. Fluorescently labeled platelets and rhodamine
dye (in experiments when leukocyte behavior was studied) were usually injected
approximately 2-10 min before releasing the occlusion, and the lung was
examined to confirm the absence of platelets in the pulmonary circulation. After
releasing the occlusion, arterioles were examined after 0.5, 1, and 2 h of
reperfusion.
The specific aim #2 was to examine if platelet and/or lung tissue P-selectin is
involved in platelet-arteriolar wall interactions during pulmonary reperfusion.
This aim was investigated by examining the effects of 2-h pulmonary ischemia
with and without blocking P-selectin, on platelet-arteriolar wall interactions and
vasoconstriction during reperfusion. To assess the general role of selectins in
mediating the platelet responses during reperfusion of the intact lung, Fucoidan
was given systemically throughout the reperfusion period in a group of animals.
To investigate the role of platelet P-selectin, monoclonal antibodies with a high
specificity for immuno-neutralization of rabbit P-selectin, were mixed with the
platelet sample 15 min before injection in another group of animals. In separate
animals, as a control before injection, labeled platelets were pretreated with the
nonspecific IgG I K antibody. P-selectin expression in lung tissue after IR was
detected by immunohistochemistry. Concentration of soluble P-selectin (sPselectin) was measured in plasma samples from the left atrium by ELISA.
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The specific aim #3 was to investigate if there is an increase in iNOS activity
which leads to RNS formation and P-selectin-dependent platelet-arteriolar wall
interactions during reperfusion. This aim was investigated by examining the
effects of 2-h pulmonary ischemia on platelet-arteriolar wall interactions and
vasoconstriction during reperfusion in the presence or absence of iNOS inhibitor.
In the animals after 2-h pulmonary ischemia, during reperfusion, an iNOS
blocker (1400W, 10 mg/kg) was infused through the right jugular vein catheter.
To verify that RNS can cause platelet activation, peroxynitrite was applied
topically in a 100 /-11 aliquot to subpleural arterioles in animals without IR.
Effects of IR on iNOS expression and activity were examined by Western
blotting and radioimmunoassay of lung tissue. P-selectin IRNS expression in
lung tissue and concentration of sP-selectin after IR were detected by
immunohistochemistry and ELISA (Fig.5).

Data analysis. Arterial blood pressure, heart rate, and tracheal pressure were
recorded continuously and measurements were taken during microvascular
observations. Each measurement period lasted for approximately 30 s. In each
animal, one to three arterioles and approximately three branches of each vessel in
the area of interest were examined. Platelet determinations were averaged for
each observation so that each animal counted equally in the analysis. Arterioles
were observed during a control period, during pulmonary artery occlusion, and at
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0.5, 1 and 2 h during reperfusion of the ischemic lung. Values are reported as
mean ± SEM. Differences between observation periods and between groups were
compared by one-way analysis of variance (ANOVA) with repeated
measurements and multiple comparisons (consideration given to within-sample
variability of observations). When comparing the means of only two
experimental groups, a non-paired t-test was used. Correlation coefficient (r) and
the linear regression analysis were used to test the relationship between two
variables. A probability level of p<0.05 was used to indicate statistical
significance.
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CHAPTER III

RESULTS

Mean arterial blood pressure and heart rate for all animals (n=50)
averaged 81 ± 6 mm Hg and 193 ± 7 beats/min during baseline before occlusion
and they were not significantly different when the lungs were statically inflated
for observations. In the different experimental groups there were no significant
differences in blood pressure or heart rate (Table 1). During reperfusion at 0.5,
1.0, and 2.0 h of reperfusion, blood pressure generally tended to be lower (72 ± 3
mm Hg, 71 ± 3 mm Hg and 73 ± 4 mm Hg, respectively), but the decrease was
not significant. Heart rate also was not significantly different from the preocclusion baseline (183 ± 4 beats/min at 0.5 hand 176 ± 5 beats/min at 1.0 and
2.0 h, respectively) (Table 1).
Arterial P02, PC02 and pH before occlusion (186 ± 11 mm Hg, 42 ± 3
mm Hg and 7.39 ± 0.02, respectively) were not significantly different during
reperfusion (214 ± 8 mm Hg, 41 ± 2 mm Hg and 7.41 ± 0.03, respectively)
(Table 2). Injection of labeled platelets, Rhodamine, Fucoidan, infusion of

33

1400W, or blood sampling did not significantly affect blood pressure, heart rate,
arterial blood gases or pH.

Effect

of

IR

on

platelet-arteriolar

wall

interactions

and

arteriolar

vasoconstriction: In five animals, in which labeled platelets were injected
without occluding the pulmonary artery (control group), platelets were not found
rolling or adhered along arteriolar walls. Furthermore, arteriolar diameters did
not change significantly from baseline during a 2-h observation period.
In 12 arterioles that were examined in five animals in which the right
pulmonary artery was clipped for 5-min (sham group), diameter averaged 48 ± 4
/lm during baseline (before occlusion). After the clip was removed, diameters were

not significantly different after 0.5, 1 or 2 h (50 ± 2 /lm, 53 ± 2 /lm, and 55 ± 1 /lm
at 0.5, 1.0, and 2.0 h, respectively). In these arterioles, during reperfusion, an
insignificant amount of the labeled platelets were observed rolling (0.08 ± 0.02 %),
and no platelets were found adhered to the arteriolar wall.
In the lIR group (five animals), 16 arterioles with an average baseline
diameter of 52 ± 2 /lm before occlusion, were examined. Arteriolar diameters at
0.5 h of reperfusion were significantly less (34 ± 3 /lm, p<0.05), but soon began
to recover and at 1 and 2 h of reperfusion (45 ± 5 /lm and 48 ± 4 /lm,
respectively) were not significantly different from baseline (Fig. 7). In these
arterioles, 15.0 ± 3.2%, 13.1 ± 4.0% and 8.3 ± 2.2% of flowing labeled platelets
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were rolling at 0.5, 1, and 2 h of reperfusion respectively, but platelet adhesion
was not observed (Fig. 8). For the lIR group, the change in arteriolar diameter
did not correlate with reperfusion time, but the amount of platelet rolling
decreased as a function of reperfusion time (Fig. lOA and 10C).
In the 2IR group (six animals), 17 arterioles (3 arterioles per animal
generally) with an average baseline diameter 55 ± 3 !lm were examined. In
contrast to the lIR group, arteriolar diameters were significantly (p<0.05) less
than baseline at all three observation periods during reperfusion (31 ± 2 !lm, 34 ±
3 !lm and 40 ± 3 !lm, respectively) (Fig. 6 and 7). After 2 h of ischemia, as soon
as blood flow begun to return, platelets were rolling and adhering to arteriolar
walls (Fig. 9). Approximately twice as many platelets were observed rolling
along the arteriolar walls at 0.5, 1.0 and 2.0 h of reperfusion than in the lIR
group (Fig. 8A). In addition, platelet adhesion was increased significantly above
control throughout the 2-h reperfusion period (Fig. 8B). This observation was
consistent when the data were expressed as a fraction of the number of labeled
platelets that entered the arteriolar segment during the observation period or
normalized per area of that segment (Table 3). The number of rolling and
adhering platelets and amount of vasoconstriction tended to decrease with
reperfusion time (Fig. 8). For the 2IR group, vasoconstriction and platelet
adhesion significantly correlated with reperfusion time (Fig. 10Band 10E) and
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amount of vasoconstriction correlated with the numbers of rolling and adhered
platelets over the reperfusion time course (Fig. 11).

Leukocyte-arteriolar wall interactions and arteriolar vasoconstriction: In three
rabbits that underwent 2-h lung ischemia, in addition to platelets, the behavior of
leukocytes was also examined during the same reperfusion times (2IR+L group).
During 2 h of reperfusion, significantly more (25 ± 4.4%) leukocytes were rolling
than during baseline (Fig. l2A), but leukocyte adhesion was not observed. In contrast
to platelets (Fig. l2B), the number of rolling leukocytes was relatively constant and
did not have a tendency to decrease with progression of reperfusion time (Fig. 12A).
Platelets and leukocytes had different rolling velocities (30 ± 3 !-un/sec and 10 ± 2
/lm/sec, respectively) and were rolling at different sites (Fig. 13).

Effect of Fucoidan on platelet-arteriolar wall interactions and vasoconstriction:
Pretreatment with Fucoidan (2IR+Fucoidan group,

five animals) prevented

vasoconstriction during reperfusion after 2-h ischemia (Fig. 14). In the 13 arterioles
that were observed, average baseline diameter before occlusion (52 ± 8 /lm) was not
significantly changed during reperfusion (42 ± 4 /lm, 55 ± 8 /lm, and 47 ± 8 /lm at
0.5, 1.0, and 2.0 h, respectively). In these arterioles, there was no significant platelet
rolling or adhesion. No platelets were observed adhering in three of the five animals
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from this group. In the two remaining animals, only 0.42% of the observed platelets
were rolling, and only 0.13% were adhered during reperfusion (Fig. 15).

Effects of P-selectin monoclonal antibody on platelet-arteriolar wall interactions:
In the group in which labeled platelets were pretreated with monoclonal antibody
(2IR+MoAb group, five animals) to P-selectin before they were injected, 17
arterioles were examined. Baseline diameter (59 ± 5
at 0.5, 1 and 2 h of reperfusion (36 ± 4

~m,

~m)

42 ± 2

decreased significantly
~m

and 44 ± 4

~m,

respectively). This decrease was similar to that of the 2IR group (Fig. 14). On
average, during reperfusion, only 0.15 ± 0.03 % and 0.1 ± 0.02 % of the observed
platelets were rolling and adhering, respectively and platelet-arteriolar wall
interactions were prevented (Fig. 15).
As a control, labeled platelets were pretreated with the nonspecific IgG 1K
antibody in four separate animals (2IR+IgG group, 10 arterioles). On average,
during reperfusion, 21.0 ± 5.0 % and 2.7 ± 0.8 % of flowing labeled platelets were
rolling and adhering, respectively. This was similar to what was found in the 2IR
group (Fig. 15). Arteriolar constriction was also not prevented (62 ± 4 ~m before
and 39 ± 2 ~m at 0.5 hr, 44 ± 3 ~m at 1 h, 43 ± 5 ~m at 2 h of reperfusion). The
effectiveness of Fucoidan and MoAb treatment in preventing platelet rolling and
adhering was similar (Fig 15).
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Effects of IR on iNOS expression and activity: Lung tissues from rabbits that
underwent 2-h ischemia and 2-h reperfusion showed a significant increase (28 ±
4%) in INOS expression compared to control animals (n=5) (Fig.l6A).
Radioimmunoassay of lung tissue from this 2IR group indicated a 3 fold increase
in total NOS activity compared to control lungs (Fig. 16B). In a separate group
(five animals), after 3 h of occlusion and 2 h of reperfusion, there was 3.5 fold
increases in total NOS activity compared to control. In the animals treated with
1400W before 2 h of ischemia (2IR+ 1400W group, n=5), there was no increase
in total NOS activity (Fig. 16C).

Effect of 1400W on platelet- and leukocyte-arteriolar wall interactions: In the
2IR+ 1400W group (five animals), in contrast to the 2IR group, the number of
rolling and adhering platelets at 0.5, 1 and 2 h of reperfusion significantly
decreased (Fig. 17A). Moreover, pretreatment with 1400W prevented pulmonary
microvascular vasoconstriction during reperfusion (Fig. 17B). In the 10 arterioles
that were observed, average baseline diameter before occlusion (49 ± 6 11m) did
not significantly change during reperfusion (43 ± 5 11m, 52 ± 6 11m, and 48 ± 7 11m
at 0.5, 1, and 2 h, respectively).
In 2-h ischemic rabbits treated with 1400W, in which leukocytes were
labeled in addition to platelets (2IR+L+ 1400W group, three animals), the number
of rolling leukocytes was not significantly different from the 2IR+L rabbits during
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the reperfusion time course (Fig.l8). Pretreatment with 1400W significantly
decreased platelet-arteriolar wall interactions and vasoconstriction (Fig. 17B and
17A), but had no affect on leukocyte rolling (Fig. 18).

RNS expression in lung tissue: Immunohistochemical examination of lung tissue
after 2-h reperfusion from 2IR animals revealed that there was a significant
increase in nitrotyrosine expression compared to the control (Fig. 20B and 20C)
and lIR groups (Fig. 21). The amount of nitrotyrosine expression increased with
the duration of ischemia. There was no difference in nitrotyrosine expression in the
left (non-ischemic) lungs between any groups (Fig. 21). When the level of
nitrotyrosine expression was plotted as a function of ischemia time, there was a
high correlation (r= 0.97) (Fig. 23A). In the lungs of animals pretreated with
1400W that underwent 2-h IR, RNS expression was not different from sham
animals (Fig. 21).

Lung tissue and platelet P-selectin expression: Immunohistochemistry for Pselectin in serial lung tissue sections from the frozen blocks that were used to
detect nitrotyrosine, showed that a significant increase in P-selectin expression in
2IR animals compared to the control group (Fig. 22A and 22B). However, Pselectin expression in non-ischemic lungs was not increased (Fig. 24). Similarly
to nitrotyrosine expression, the correlation between expression of lung tissue P-
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selectin and duration of ischemia was high (Fig. 23B). Moreover, when the levels
of tissue P-selectin were plotted against RNS levels, the linear correlation was
also high (r= 0.89) (Fig. 23C).
Similarly

to

tissue

P-selectin,

soluble

P-selectin

(sP-selectin)

concentration in plasma samples was significantly increased in animals that
underwent 2-h ischemia and 2-h reperfusion compared to the controls (Fig. 25).

Effect of 1400W on platelet and lung tissue P-selectin and lung tissue
nitrotyrosine expression: Pretreatment of 2IR animals with 1400W significantly
attenuated nitrotyrosine and P-selectin expression in ischemic lung tissue (Fig.
22 and 24), as well as sP-selectin in plasma (Fig. 25).
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Table 1. Arterial blood pressure and heart rate at baseline (b-line) before
and during lung reperfusion. Values are means ± SEM; n=number of

animals. 0.5, 1.0 and 2.0 (h) are the observation time points during 2 h of
reperfusion.
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Table 1
HR (beats/min)

BP(mmHg)
n

.J:-.

N

Reperfusion (h)

Reperfusion (h)

0

0.5

1.0

2.0

0

0.5

1.0

2.0

Sham

5

83±5

75±3

72±3

73±4

192±4

179±3

178±5

174±3

Control

5

82±3

73±2

70±2

75±3

189±3

182±2

179±3

181±5

Control+RNS

4

83±4

71±3

72±3

74±3

185±7

183±5

178±5

177±4

lIR

5

77±5

77±3

70±3

78±3

197±2

184±4

180±5

180±5

2IR

6

78±3

69±2

71±2

72±2

189±3

187±3

181±5

179±3

2IR+L

3

79±4

70±3

70±6

69±4

190±7

181±6

174±6

173±6

2IR+Fucoidan

5

77±6

67±3

67±2

71±2

189±3

185±3

175±3

175±3

2IR+MoAb

5

79±4

75±4

72±2

72±6

194±5

184±4

176±4

176±4

2IR+IgG

4

78±5

77±3

75±3

74±3

188±4

183±5

172±5

172±5

2IR+1400W

5

80±3

72±3

71±4

71±4

179±2

187±3

174±3

178±5

2IR+L+1400W

3

79±6

69±5

69±4

70±5

194±5

178±5

173±6

174±6

Table 2. Arterial blood gases (P0 2 and PC0 2) and pH at baseline (b-line)
before and during lung reperfusion. Values are means ± SEM; n=number of

animals. 0.5, 1.0 and 2.0 (h) are the observation time points during 2 h of
reperfusion.
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Table 2
P0 2 (mmHg)

..j::>.
..j::>.

PC0 2 (mmHg)

pH

n

B-line

Reperf.

B-line

Reperf.

Sham

5

189±10

214±8

42±4

40±2

7.38±O.OO3 7.40±O.OO3

Control

5

192±12

233±9

44±2

41±2

7.37±O.002 7.39±O.OO3

Control+RNS

4

193±11

229±7

43±3

42±3

7.39±O.002 7.38±O.OO4

lIR

5

194±9

220±6

43±5

39±4

7.39±O.OO3 7.40±O.OO3

2IR

6

182±13

218±7

40±2

41±2

7.40±O.002 7.38±O.OO2

2IR+L

3

187±10

222±10

39±4

40±2

7.37±O.004 7.42±O.OO2

2IR+Fucoidan

5

188±12

234±9

43±2

44±3

7.38±O.002 7.39±O.OO3

2IR+MoAb

5

189±11

233±4

42±3

41±4

7.39±O.002 7.41±O.OO3

2IR+IgG

4

183±8

224±8

41±1

43±2

7.38±O.OO3 7.40±O.OO3

2IR+1400W

5

180±13

225±7

42±3

45±2

7.40±O.002 7.38±O.OO4

2IR+L+1400W

3

179±14

219±9

41±4

40±3

7.39±O.OO2 7.41±O.OO3

B-line

Reperf.

Table 3. Labeled platelets rolling or adhered during reperfusion after 2 h
of ischemia. Values are means ± SEM; n=number of arterioles in 6 animals.
Note that there were no differences between the values for rolling or adhered
platelets at 0.5, 1.0, or 2.0 h of reperfusion expressed by different methods.
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Table 3

Reperfusion time

Platelets / mm2
.J::>.

0\

Platelets / mm2/
/ platelets flowing
Platelets/
/platelets flowing x 100 (%)

0.5 hr
(n =17)
Rolling Adhered

1.0 hr
(n =18)
Rolling Adhered

2.0 hrs
(n =18)
Rolling Adhered

852±170

159±39

771±106

127±15

607±70

115±20

11.7±1.8

3.5±0.7

10.3±1.3 2.9±0.55

9.2±1.2

2.2±0.4

26.5±4.3

4.5±0.9

22.0±2.9

20.5±2.8

3.7±0.4

4.1±0.5

ulmonary
IR in'u

Arteriolar
constriction

Platelet
adhesion

iN OS

"\
NO

NADPH
oxidase
.

I.
'.

_<IiIiiID"....

Endothelium

Nitrotyroslne

Figure 1. General hypothesis. In the oxidative stress induced by
pulmonary IR, formation of RNS may promote platelet activation and
adhesion to the arteriolar wall with subsequent release of vasoactive
substances and vasoconstriction. We examined the hypothesis that pulmonary
IR induces 'platelet-arteriolar wall interactions via a P-selectin dependent
mechanism and contribute to pulmonary microvascular constriction during
reperfusion. Increased P-selectin expression results from elevated iNOS
activity and subsequent RNS generation.
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Adhesion

sP-se/ectin

P-selectin

P-se/ectln

Figure 2. Schematic diagram of P-selectin and P-selectin glycoprotein
ligand (PSGL-l). Upon stimulation, P-selectin is expressed on the surface of
platelets and endothelial cells. Platelet P-selectin can be cleaved, generating
the soluble fragment of P-selectin (sP-selectin). PSGL-I is constitutively
expressed on the surface of endothelial cells and leukocytes. P-selectin is able
to trigger tyrosine phosphorylation of several cytoplasmic proteins via
interaction with PSGL-l. This leads to the activation of integrins and
subsequent firm platelet adhesion to the endothelium (168).
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Arleria/line

~~S lino

;

;

Window for lung
observ.:nlon

Figure 3. Experimental model. The subpleural pulmonary arterioles were

observed in anesthetized rabbits with open chest and ventilated lungs using
intravital video microscopy. IR was caused by reversibly occluding the right
pulmonary artery.
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VCR

Timer

Video Monitor
lOOW
HgArc

Fluorescence
Filter
Heat Filters

Eyepiece

Collector
Lens

L10 Iris
Objective Lens

Dipping Cone

C::::O<:::;::> =

=

Lung Surface

c:::>

Figure 4. Intravital video microscopy system. Drawing of the incident
illumination microscope with attached video camera. The objective lens (LlO
iris) was attached to a glass dipping cone.
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Figure 5. Experimental protocols. Subpleural arterioles, platelets and

leukocytes were examined by intravital fluorescence microscopy. Ischemia
was caused by reversibly occluding the right pulmonary artery for different
periods of time (5 min, 1 h or 2h) and the right lung was observed after 0.5, 1
and 2 h of reperfusion. The different protocols included systemic pretreatment
with Fucoidan (a selectin ligand), 1400W (iNOS inhibitor), labeled platelets
treated with P-selectin monoclonal antibody (MoAb) or nonspecific IgG 1K
antibody. At the end of experiments, the lungs were removed for iNOS
expression

or

NOS

activity

measuring

and

P-selectinlNitrotyrosine

immunohistochemistry. The plasma samples were taken before and after
reperfusion for soluble P-se1ectin measuring.
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Figure 6. Responses of a subpleural pulmonary arteriole to 2-h ischemia.

A and B, at beginning and end of the baseline peri od; C-F, during reperfusion
after 10, 30, 60 and 120 min respectively.
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Figure 7. Comparison of effects of 1 hand 2 h of pulmonary ischemia

011

changes in pulmonary arteriolar diameter during reperfusion. HR, \-h
ischemia-reperfusion group; 2IR, 2-h ischemia-reperfusion group.

*

P<O.05 for comparison of lIR and 2IR groups. n= number of animals.

54

denotes

Figure 8. Platelet-arteriolar wall interactions during reperfusion of the
right lung after Ih and 2 h of pulmonary ischemia-reperfusion. (A)
Rolling platelets. (B) Adhering platelets. Scale bars indicate means ± SEM, n =
number of animals.

* denotes P<O.005 for comparison of lIR and 2IR. t

denotes no significant adhesion.
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Figure 9. Adhered platelets in a pulmonary arteriole in the right lung
observed by intravital fluorescence microscopy during reperfusion after a
2-h pulmonary ischemia. (A) During occlusion of the right pulmonary artery

after labeled platelets were injected (8 min before reperfusion). Note that no
labeled platelets were present. (B) After 14 min of reperfusion. (C) After 70
min of reperfusion. (D) After 124 min of reperfusion. Arrows indicate
examples of platelets adhered to the arteriolar wall.
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Figure 9
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Figure 10. Correlation between arteriolar constriction or platelet
rolling/adhesion with duration of reperfusion. A - Arteriolar constriction vs.

reperfusion time in lIR group (A) and in 2IR group (B). Amount of platelet
rolling after I-h ischemia (C) and 2-h ischemia (D) vs. reperfusion time.
Amount of platelet adhesion after 2-h ischemia vs. reperfusion time (E). Note
that correlation coefficients (r) on panel (A) and (D) are low.
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Figure 11. Arteriolar constriction as a function of platelet rolling or
adhesion during reperfusion. A - after I-h ischemia, Band

c.-

after 2-h

ischemia. Note that after I-h ischemia platelet adhesion was not different from
baseline.
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Figure 12. Platelet and leukocyte rolling in the right lung during the
reperfusion time course after 2 h of pulmonary ischemia-reperfusion. (A)
Rolling platelets. (B) Rolling leukocytes. Scale bars indicate means ± SEM, n
=

number of animals.

* Indicates P<O.05. t denotes no significant rolling.

63

Rolling leukocytes/mm 2
(.II

C>
C>

....

....

'"o

g

C>
C>
C>

(.II

o

a
01

*

:::0
CD

liD
N OJ
n>
:::0 (/)

CD

r+

~.o

:J
II

"C

4...,Jo.
c.

*

a

:J

....-

»

o

CD
:J
CD

0J

':J
...-

N

a

*
OJ

Rolling platelets/mm 2/platelets flowing

*

*

Figure 12

64

Figure 13. Rolling and adhered platelets (A and C) and leukocytes (B and
D) in a pulmonary arteriole observed by intravital microscopy. Circles
indicate regions shown in inset boxes enlarged 2X. In A and C (1.2 sec later),
white arrows indicate a rolling platelet and black arrows indicate adhered
platelets. In Band D (1.2 sec later) the stripped arrows indicate rolling
leukocytes. Note that the platelets and leukocytes had different rolling speed
(30 ,"un/sec and 10 /-lmlsec respectively) and adhered and rolled at different
sites.
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Figure 13
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Figure 14. Comparison of effects of MoAb or Fucoidan treatment on
changes in pulmonary arteriolar diameters during the reperfusion time
course after 2 h ischemia. 2IR, ischemia-reperfusion alone (21 arterioles in 6
animals); IR+MoAb, ischemia-reperfusion plus labeled platelets treated with
monoclonal antibody to P-selectin (17 arterioles in 5 animals); 2IR+Fucoidan,
ischemia-reperfusion plus treatment with Fucoidan (13 arterioles in 5 animals)
given I.V.* denotes P<O.005 for comparison of 2IR+Fucoidan with 2IR and
IR+MoAb groups.
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Figure 15. Platelet-arteriolar wall interactions during reperfusion of the
right lung after 2 h of pulmonary ischemia-reperfusion. (A) Rolling
platelets. (B) Adhering platelets. Scale bars indicate means ± SEM, n = number
of animals. 2IR, 2-h ischemia-reperfusion. IgG, nonblocking antibody. MoAb,
anti-P-selectin monoclonal antibody.

*

Indicates P<O.OOI comparing of 2IR

with 2IR+Fucoidan, 2IR with 2IR+MoAb and 2IR with 2IR+1400W. Note that
there were no significant differences between 2IR group and 2IR+IgG group.
Note that there were no significant differences between 2IR+Fucoidan group,
2IR+MoAb group and 2IR+ 1400W group.
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Figure 16. iNOS expression (A and B) and total NOS activity (C) in the
right lungs. A and B: after 2h of ischemia; C: after 3 h of ischemia with and
without 1400W treatment. Scale bars indicate means ± SEM. n
animals.

* Indicates p<O.05.
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Figure 17. Platelet rolling (A) and arteriolar constriction (B) during
reperfusion time course in 2IR group compare to 2IR+ 1400W group.
Scale bars indicate means ± SEM. n = number of animals.
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* Indicates P<O.03.
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Figure 18. Platelet and leukocyte rolling during reperfusion of the right
lung after 2 h of pulmonary ischemia-reperfusion. (A) Rolling platelets.
(B) Rolling leukocytes. Scale bars indicate means ± SEM, n = number of
animals.

* Indicates P<O.05.
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Figure 19. Platelet adhesion in subpleural arterioles after topical
application of 1 flM peroxynitrite (in 100 flm). A, before application; B, 15
s after application; C, 16 s after application; D, 25 s after application. Arrows
indicate examples of platelets adhered to the arteriolar wall.
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*

Figure 20. Comparison of nitrotyrosine expression as a marker of RNS in
lung tissue after 2 h of ischemia with and without 1400W treatment.
Fluorescence (green) shows positive nitrotyrosine immunostaining. A,
negative control; B, non-ischemic lung (control). Note greater nitrotyrosine
immunostaining with 2 IR (C) was prevented by 1400W (D).
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Figure 20
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21R

11R
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Figure 21. Effect of pulmonary ischemia with and without 1400W
treatment on nitrotyrosine expression in lung tissue. Scale bars indicate
means ± SEM. n
groups;

t

=

number of animals. * Indicates P<O.05 compared to all

Indicates P<O.05 compared 2IR ischemic and non-ischemic (sham)

groups.
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Figure 22. Comparison of immunofluorescence staining of P-selectin in

lung tissue after 2 h of ischemia and 2 h of ischemia with 1400W
treatment.

Fluorescence

(green,

arrows)

shows

positive

P-selectin

immunostaining (arrows). A, non-ischemic lung (control). Note greater P-selectin
immunostaining in 2 IR (B) compared to control (A) and 2 IR+ 1400W (C). D,
trichrome staining for the section which was taken from the same 2IR block shown
in panel B (the area of interest is framed).
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Figure 22
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Figure 23. Scatter diagram of lung P-selectin, plasma P-selectin, and lung
nitrotyrosine expression from animals that underwent no ischemia, 5min, I-h, or 2-h lung ischemia. Correlation coefficient (r) obtained by linear
regression. n=number of animals. A, correlation of nitrotyrosine; B, tissue Pselectin expression versus duration of ischemia; C, correlation of P-selectin
expression versus nitrotyrosine expression after 2-h ischemia and reperfusion.
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Figure 24. Effect of ischemia duration and 1400W treatment on P-selectin
expression in lung tissue after 2 h of reperfusion. Scale bars indicate means
± SEM. n

=
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Figure 25. Effect of pulmonary 2IR with and without 1400W treatment on
concentration of soluble P-selectin in plasma after 2 h of reperfusion. Scale

bars indicate means ± SEM. n

= number of animals. * Indicates P<O.05

compare to all groups
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Figure 26. Effects of 1400W treatment on platelet-arteriolar wall
interactions during reperfusion of the right lung after 2 h of pulmonary
ischemia-reperfusion. (A) Rolling platelets. (B) Adhering platelets. Scale
bars indicate means ± SEM. n = number of animals.
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Figure 27. Comparison of effects of 1400W treatment on changes in
pulmonary arteriolar diameters during the reperfusion time course after
2 h ischemia. 2IR, ischemia-reperfusion alone (21 arterioles in 6 animals);
and 2IR+1400w, and 1400W (18 arterioles in 5 animals) given LV.
P<O.05.
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Figure 28. Comparison of effects of MoAb, Fucoidan or 1400W treatment
on changes in pulmonary arteriolar diameters during reperfusion after 2
h ischemia. 2IR, ischemia-reperfusion alone (21 arterioles in 6 animals);

IR+MoAb,

ischemia-reperfusion

plus

labeled

platelets

treated

with

monoclonal antibody to P-selectin (17 arterioles in 5 animals); 2IR+Fucoidan
and 2IR+ 1400w, ischemia-reperfusion plus treatment with Fucoidan (13
arterioles in 5 animals) and 1400W (18 arterioles in 5 animals) given LV. *
denotes P<O.005 for comparison of 2IR+Fucoidan and 2IR+ 1400W with 2IR
and IR+MoAb groups.
with 2IR+ 1400W group.

A

denotes P<O.005 for comparison of 2IR+Fucoidan

t denotes no significant constriction.
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Figure 29. Platelet-arteriolar wall interactions during reperfusion of the
right lung after 2 h of pulmonary ischemia-reperfusion. (A) Rolling
platelets. (B) Adhering platelets. Scale bars indicate means ± SEM; n
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number of animals; 2IR, 2-h ischemia-reperfusion; MoAb, anti-P-selectin
monoclonal antibody. * Indicates P<O.OOl. Note that there were no significant
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Figure 31. Effect of pulmonary ischemia on nitrotyrosine expression in
lung tissue (A), P-selectin expression in lung tissue (B), and plasma
soluble P-selectin (C) after 2 h of reperfusion. Scale bars indicate mean ±
SEM, n=number of animals. /\ Indicates p<O.05 compared to all samples
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CHAPTER IV

DISCUSSION

1. Effects of IR platelet- and leukocyte-arteriolar wall interactions and arteriolar
vasoconstriction during lung reperfusion
Specific aim #1 addressed the hypothesis that pulmonary ischemiareperfusion induces platelet-arteriolar wall interactions and contributes to
pulmonary microvascular constriction during reperfusion by determining if
platelet-arteriolar wall interactions occur during lung reperfusion and if they could
contribute to pulmonary postischemic microvascular constriction.

During reperfusion of the ischemic lung, platelets were observed rolling
and adhering along arteriolar walls when blood flow returned. This process was
proportional to the duration of ischemia and did not occur during normal
conditions, or in response to a brief occlusion (5 min). By observing individual
arterioles over the time course of reperfusion after prolonged ischemia, we found
that platelet rolling and adhesion occurred at the beginning of reperfusion (Fig.9).
As the ischemic duration increased, the numbers of rolling and adhered platelets
increased (Fig.8). After I h of ischemia, platelet rolling increased significantly, but
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there was no adhesion. The amount of platelet rolling in the 2IR group increased
about two fold compared to the lIR group. In addition, after 2-h of ischemia,
platelet adhesion increased dramatically. To our knowledge, platelet rolling and
adhesion in subpleural arterioles during reperfusion of the intact, ventilated lung,
has not been reported previously. Our findings are consistent with the results of
others who found that platelets do not normally interact with the endothelium in
the systemic microvasculature unless there is some level of activation (2).
Comparing velocities of unstimulated platelets with thrombin-activated platelets in
pulmonary arterioles, Eichorn et al. (2002) found that platelet-endothelial
interactions do not occur unless platelets are activated (9). This observation
indicates that the level of platelet adhesion is in proportion to the degree of injury
and/or products produced in postischemic tissue.
Our results also show that reperfusion of the lung after 2-h ischemia causes
arteriolar diameter to decrease, which subsequently would affect alveolar
perfusion. Typically, during reperfusion, we observed that alveolar walls became
pale, indicating lack of perfusion. Constriction was greatest at the beginning of
reperfusion and continued for at least 2 h, gradually recovering. Similar to platelet
rolling and adhesion, the amount of postischemic vasoconstriction was also
proportional to the length of ischemia. Control conditions, or brief occlusion, did
not decrease arteriolar diameter. After I-h of ischemia, diameter was significantly
decreased during the first 0.5 h of reperfusion, but by 1 h returned to the baseline
(Fig.7). As previously shown using the same model of IR (29), a decrease in
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arteriolar diameter during reperfusion corresponded with an increase in pulmonary
vascular resistance without a significant change in pulmonary artery pressure or
pressure gradient across the lungs. Systemic arterial blood pressure and heart rate
did not significantly change throughout our experiments, and the results did not
appear to be due to a general haeomodynamic change (Table 1). However, at the
very beginning of reperfusion, decreased microvascular diameter could be passive
if some vessels are not opened by returning blood flow. It is unlikely that
vasoconstriction during reperfusion was due to hypoxia, since P02 was kept above
100 mmHg. In addition, arterial PC02 and pH before occlusion were not
significantly different throughout the experiments (Table 2). Therefore, the
decrease in arteriolar diameter is indicative of vasoconstriction.
During reperfusion after I-h and 2-h ischemia, the amount of plateletarteriolar wall interactions and amount of arteriolar constriction, tended to
decrease with progression of reperfusion time. In the 2IR group, there was a
stronger correlation between vasoconstriction with reperfusion time (r=0.85) than
in the lIR group (r=0.6) (Fig.l OB and lOA). In addition, in the 2IR group, the
decrease in platelet adhesion correlated with reperfusion time (r=0.8), but the
number of rolling platelets did not (r=0.66) (Fig.lOD and IOE). Throughout
reperfusion, the amounts of arteriolar constriction and platelet adhesion were
highly correlated to each other (r=0.96) (Fig.lIC).
After I-h occlusion, platelet rolling was significantly greater than control.
Arteriolar diameters were only significantly decreased during the first 0.5 h of
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reperfusion, and platelet adhesion was not observed (Fig.7 and 8). In contrast, during
reperfusion after 2 h of ischemia, an increased amount of platelet rolling was
accompanied by increased of platelet adhesion and indicates that a certain amount of
platelet rolling precedes the firm adhesion. This is consistent with the results of others
who reported that P-selectin-PSGL-I interactions trigger a functional upregulation of
integrins (CDllb/CDI8, Mac-I) which mediate firm adhesion of platelets and
leukocytes (168). The observation that after 1 h of ischemia at 0.5 h of reperfusion,
arteriolar constriction was not accompanied by platelet adhesion indicates that not all of
the decrease in pulmonary arteriolar diameter (especially at 0.5 h) is platelet mediated.
Platelet- and leukocyte-endothelial interactions involve selectin dependent
mechanisms and both are implicated in microvascular dysfunction associated with
IR (151). The primary ligand for P-selectin, PSGL-l, is constitutively expressed
mostly on endothelial cell and leukocyte membranes (173) and it is possible that
platelet rolling along arteriolar walls could be facilitated by interaction of platelet
and/or endothelial P-selectin with PSGL-l expressed on leukocytes. We did
experiments to determine if postischemic platelet-arteriolar wall interactions and
vasoconstriction could occur independently of leukocyte adhesion. According to
our observations, leukocyte rolling was a separate process from plateletendothelial interactions and leukocyte adhesion did not occur during 2-h
reperfusion following 2-h ischemia. We found that postischemic platelet-arteriolar
wall interactions and vasoconstriction can occur independently of leukocyte
adhesion. Platelet, but not leukocyte rolling and adhesion along arterioles correlated
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with microvascular constriction. Pretreatment with an iNOS inhibitor (1400W)
significantly

decreased

platelet

rolling,

adhesion

(Fig.30B,

30C)

and

vasoconstriction (Fig.30A), but had no significant effect on leukocyte rolling or
adhesion (Fig.I8). Moreover, when observed simultaneously, platelets and
leukocytes had different rolling velocities and were rolling at different sites (Fig. 13).
These results suggest that platelet activation during early reperfusion in the
ventilated lung

IS

a more significant factor than leukocyte activation in

contributing to postischemic arteriolar constriction and decreased alveolar
perfusion. This observation is consistent with previous reports that lung IR injury
consists of an early (first 2 h of reperfusion) leukocyte-independent phase (10).
However, our results do not exclude the possibility that platelet-endothelial
adhesion can also involve leukocyte interactions. In morphologically intact
endothelium, Kirton and Nash (2000) found that even small numbers of platelets
adhered to the endothelium have the potential to capture flowing neutrophils and
facilitate their immobilization at the vessel wall and promote inflammatory and
thrombotic interactions (77).
Although, platelet activation and accumulation are implicated in causing
reperfusion injury in tissues such as intestine, liver, pancreas, brain, and kidney
(25,43,45), the kinetics of platelet-arteriolar wall interactions during lung
reperfusion was not described previously. Moreover, the relationship between
length of pulmonary ischemia, platelet adhesion and postischemic arteriolar
vasoconstriction has not been reported previously. Our results indicate that the
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level of platelet adhesion is in proportion to the degree of IR injury and can be
associated with products produced in postischemic tissue.

2. Role of platelet P-selectin in platelet-arteriolar wall interactions and
vasoconstriction during lung reperfusion
Specific aim #2 focused on the role of platelet and lung tissue P-selectin
and addressed the hypothesis that pulmonary IR induces platelet-arteriolar wall
rolling and adhesion via a P-selectin dependent mechanism, and contributes to
pulmonary microvascular constriction during reperfusion.

We found that P-selectin expressIOn

In

lung tissue was increased

significantly in lIR and 2IR animals compared to the control group (Fig. 22A,22B
and 24) and that there was a high correlation (r=0.85) with the duration of
ischemia (Fig. 23B). Soluble P-selectin (sP-selectin) concentration in plasma
samples, which is used as a measure of platelet P-selectin expression (85), was
also significantly increased in animals that underwent 2-h ischemia and 2-h
reperfusion, compared to the level of sP-selectin before occlusion (Fig. 25).
Platelet rolling and adhesion during reperfusion after two hours of ischemia
was significantly inhibited by Fucoidan (Fig 15), which also inhibited arteriolar
constriction (FigI4). Fucoidan is a polysaccharide ligand for P- and L-selectins
that helps mediate the initial rolling and adhesion of activated leukocytes and
platelets along endothelial cells (5,12,25). Others showed that Fucoidan, by
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interacting with selectins, prevented neutrophil and platelet rolling, adhesion, and
accumulation during lung inflammation (40), myocardial IR injury (33) and
inhibited vasoconstriction associated with selectin-mediated arterial injury (6).
The effectiveness of Fucoidan in the present experiments suggests that the platelet
rolling and adhesion, that we observed in the pulmonary microcirculation during
reperfusion, was at least in part, mediated by expression of P-selectin expressed by
platelets and endothelial cells.
When platelets or endothelial cells are activated by stimuli such as
thrombin, histamine, and reactive oxygen species (16,28), P-selectin is rapidly
translocated to the external membrane where it mediates binding to platelets,
leukocytes and endothelial cells. In the present study, pretreatment of labeled
platelets with an anti P-selectin monoclonal antibody dramatically decreased the
IR injury-induced platelet rolling and adhesion to the arteriolar wall (FigI5).
Pretreatment of the labeled platelets with the isotype matched non-blocking
antibody (IgG 1K), did not prevent these platelet-endothelial interactions. These
results suggest that P-selectin has a major role in mediating platelet-endothelial
rolling and adhesion in pulmonary arterioles during post-ischemic reperfusion of
the lung. Our results are consistent with the finding of others that systemic
treatment with P-selectin monoclonal antibodies significantly reduces the adhesion
of leukocytes and platelets to endothelium after middle cerebral artery occlusion
and reperfusion (183). Akers et al (1997) reported that treatment with P-selectin
monoclonal antibody attenuated endothelial-dependent relaxation and restoration
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of endothelium after endothelial damage during balloon catheterization (1). In our
experiments, in contrast to systemic administration of Fucoidan which binds Pand L-selectin throughout the body, treatment of only the labeled platelets with
antibody to P-selectin, which inhibited platelet rolling and adhesion, did not
inhibit arteriolar constriction (Fig.l4). This result is expected if the endogenous
non-treated platelets are free to interact with the endothelium. The non-blocking
antibody (lgG I K) had no obvious effect on platelet rolling, adhesion, or arteriolar
vasoconstriction during reperfusion. Taken together, these results suggest that
vasoconstriction did not cause platelet rolling and adhesion.
Even inactivated platelets may have a small quantity of P-selectin on their
surface (31). It is possible that the platelets that were prepared for injection already
activated to some degree by the labeling procedure. Such activation however,
would not adequately explain the increased rolling and adhesion caused by IR,
since rolling and adhesion did not occur with the same platelet preparation in
control (non-ischemia) experiments. The small amount of monoclonal P-selectin
blocking antibody that was added to the platelets (25 flg) prior to injection was
about 500 times less than the dose used by others in rabbits to block P-selectin
systemically (17). Thus, in our experiments, it is not likely that we completely
blocked endothelial P-selectin by adding anti P-selectin antibody to the platelets.
Our data, while strongly indicating involvement of platelet P-selectin, does not
exclude a role for endothelial P-selectin in the platelet rolling and adhesion during
IR in the rabbit lung. Systemic administration of anti-P-selectin antibody would
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block endothelial as well as platelet P-selectin, and also would not exclude the role
of endothelial P-selectin. Other molecules could also be interacting with platelet Pselectin. Possible ligands for P-selectin that have been suggested include
GlyCAM-l, CD34 and MadCAM-l (27). Expression of GlyCAM-l and
MadCAM-l (38) for example, have been found to be elevated during IR-induced
lung injury and could also have a role in the platelet responses that we observed.
The results of our experiments demonstrate a significant role of platelet P-selectin
in initiation of platelet adhesion in IR, but do not exclude the role of other
adhesion molecules in post-ischemic platelet rolling and adhesion.
Upon stimulation, endothelial cells in venules of most organs express Pselectin, but expression in arterioles generally appears to be less (41). Although
mouse arterioles express a very low level ofP-selectin in response to stimulation (19),
evidence of significant endothelial P-selectin-dependent platelet adhesion has been
reported in this species (25). In the mouse intestine, after one hour of ischemia,
Massberg (25) observed that platelets rolled along, or firmly adhered to endothelial
cells of arterioles and venules in a manner similar to what has been described for
leukocytes. Monoclonal antibodies to P-selectin, given systemically, attenuated
platelet rolling and adherence in response to ischemic reperfusion. When P-selectin
expression in the intestinal microcirculation was enhanced by IR, no change in
platelet immunoreactivity of P-selectin was found during post-ischemic reperfusion
(25). Results from their experiments in genetically altered mice indicated that the IR
platelet-endothelium interactions were dependent on expression of P-selectin by
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endothelial cells. In our experiments, examination of reperfused lung tissue after 1 or
2 h of ischemia showed consistent correlation between tissue P-selectin expression
and length of pulmonary ischemia. These results strongly suggest that in plateletarteriolar wall interactions, both platelet and endothelial P-selectin may be involved.
Platelet accumulation is implicated as a cause of tissue injury during
reperfusion of various organs (3,25,32,39,42). In the isolated perfused dog
pancreas and liver, leukocyte and platelet depletion reduced cell damage caused by
reperfusion after one hour of ischemia (22,23). Injury was associated with
increased production of reactive oxygen species and thromboxane A2, and
decreased production of prostaglandin 12 , The authors (11,35) suggested that
platelets were a likely source of the thromboxane A2 and other pro-inflammatory
mediators. Furthermore, P-selectin expressed on already activated platelets,
mediates their binding to leucocytes and may lead to release of neutrophil
proteases, which are important extracellular signals for further platelet recruitment
and amplification (20). Platelet-induced accumulation of leukocytes and
particularly neutrophils, can cause damage of the pulmonary vessel wall and may
lead to ventilation/perfusion mismatch (21,30).
In addition to the mechanisms described above concernmg platelet
activation and accumulation, the endothelium normally acts to prevent coagulation
and has an important role in production of vasoactive metabolites, which affect
platelet activity as well as vascular tone. Endothelial synthesis of nitric oxide for
example, decreases platelet aggregation as well as adhesion, and as a vasodilator,
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generally favors anticoagulation by reducing shear stress (2). IR modifies the
synthesis and release of substances such as reactive oxygen and nitrogen species,
thromboxane A 2, platelet activating factor, and serotonin by endothelial cells and
platelets and promotes platelet aggregation and accumulation in microvasculature.
In addition, IR injury can cause platelet activation, adhesion, and aggregation by
disrupting the endothelium and exposing platelets to subendothelial matrix
components (2). Von Willebrand factor, for example, causes platelets to adhere to
the sub-endothelium at sites of vascular injury and to become activated (16). Thus,
there are numerous mechanisms in addition to those that involve P-selectin, which
could also affect platelet activation and adhesion in the present study.

3. Role of iNOS and RNS in platelet- arteriolar wall interactions and
vasoconstriction during lung reperfusion
Specific aim #3 examined if an increase in iNOS activity could lead to RNS
formation and P-selectin dependent platelet-arteriolar wall interactions during
reperfusion. This aim addressed the hypothesis that pulmonary ischemia-reperfusion
induces platelet-arteriolar wall interactions via increased P-selectin expression resulting
from elevated iNOS activity and subsequent RNS generation.

When animals were pretreated with an iNOS inhibitor (1400W) before 2-h
ischemia and 2-h reperfusion, platelet rolling and adhesion, as well as microvascular
constriction, were prevented (FigJO). This finding suggests that a consequence of NO
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production resulting from increased iNOS activity influences platelet-arteriolar wall
interactions and vasoconstriction. To our knowledge, this effect of iNOS inhibition on
platelet-arteriolar wall interactions during IR has not been previously reported.
Examination of postischemic lung tissue showed that iNOS expression and
activity increased in our model of IR. The increase in activity was much greater than
the increase in expression. This finding suggests the idea that the increase in the rate
of expression lags the increase in enzyme activity. Further expression of iNOS
requires an additional synthesis which is time-dependent (56,57). Furthermore, the
increase in total NOS activity was prevented by 1400W, indicating that increased
iNOS expression and activity could likely cause NO overproduction in response to
ischemia and reperfusion (Fig.16). Low concentrations of NO, constitutively
produced by eNOS, inhibit platelet (157,161), leukocyte and endothelial activation
(78,119). Since iNOS has been suggested to be responsible for platelet activation
during IR injury (134,160), and P-selectin is implicated in these processes (146,165),
we hypothesized that overproduction of inducible NO leads to RNS formation and
subsequent platelet activation through a P-selectin dependent mechanism.
NO reacts with oxygen radicals which lead to formation of RNS, such as
peroxynitrite (65), which is especially relevant in the high oxygen environment of
the ventilated, but not perfused lung. Nitrotyrosine is an RNS footprint that has been
detected in pathological conditions including IR (111,153). Peroxynitrite is a
selective oxidant that reacts with biological molecules and modifies tyrosine in
proteins to create nitrotyrosine. It has been reported that ROS and RNS scavengers,
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such as superoxide dismutase (superoxide scavenger) and catalase (hydrogen
peroxide scavenger), decrease platelet activation and reperfusion injury
(141,142,162). Examination of lung tissue after 1 and 2 h of ischemia and 2 h of
reperfusion showed that there was a significant increase in nitrotyrosine
expression (Fig. 20 and 21). Nitrotyrosine levels in lung tissue subjected to IR
correlated with the length of ischemia and which were prevented by iNOS
blocking (Fig. 31A). Correlation between RNS expression and platelet adhesion
suggests that RNS could be a mediator of platelet-arteriolar wall interactions. The
present finding that topical application of RNS (peroxynitrite) to subpleural
arterioles caused platelet adhesion to the arteriolar wall (Fig.19) indicates that
RNS could cause platelet activation in the pulmonary microvasculature.
There was a consistent correlation between RNS formation and tissue Pselectin expression (Fig. 23). Pretreatment with 1400W decreased RNS formation and
lung tissue expression of P-selectin (Fig.24). Increased iNOS activity has been
suggested to have a role in platelet activation in several vascular beds via RNS
formation and a P-selectin mediated process (56,119,160). Thus, in the case of blood
returning to the ischemic, but ventilated lung, it is likely that overproduction of NO
via iNOS leads to RNS formation and subsequent platelet activation through a Pse1ectin dependent mechanism. When iNOS was blocked by 1400W in 2IR animals,
nitrotyrosine expression was not different from the sham group (Fig.21). Although
1400W is a "selective" iNOS inhibitor, it is possible that it could have other actions.
Our findings generally agree with what others have reported with regard to iNOS
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inhibition of vascular responses and are similar to what has been found with regard to
another iNOS inhibitor such as aminoguanidine (66,166,184).
It is likely that P-selectin expression in lung tissue was from the endothelium, but
not platelets, since the lungs were flushed with saline before harvesting. However, we
have not determined whether the endothelial P-selectin was expressed in arterioles or
venules. We also found that the level of plasma P-selectin, which represents platelet Pselectin expression (176), increased during reperfusion. Moreover, pretreatment with
1400W inhibited lung tissue and plasma expression of P-selectin. This finding suggests
that the platelet-endothelial interactions in arterioles of the reperfused rabbit lung were
mediated, at least in part, by platelet P-selectin. The present data indicate that P-selectin
could be involved in platelet-endothelial interactions, but does not allow distinction
between the contribution of platelet or endothelial P-selectin expression in this process.
Although leukocyte-endothelial interactions also involve selectin dependent mechanisms
and are implicated in IR-induced microvascular dysfunction (124), leukocytes do not
appear to be required for the platelet adhesion observed in the present study (Fig. 13).
The present experiments demonstrate that during pulmonary IR in the intact
ventilated lung, platelets roll and adhere along pulmonary arterioles in proportion to the
length of ischemia. The mechanism of those postischemic platelet-endothelial
interactions appears to involve excess production of NO via iNOS which leads to
fonnation of RNS and may result in increased expression of P-selectin. During lung
reperfusion, platelet activation and adhesion in arterioles is associated with
vasoconstriction that would reduce alveolar perfusion and may be a significant
112

component of pulmonary IR injury. Correlation between the length of lung ischemia,
postischemic arteriolar vasoconstriction, and its relation to formation of RNS and Pselectin, strongly suggest that NO overexpression by iNOS may induce formation of
RNS and increase platelet and endothelial P-selectin expression during lung IR (Fig. 31).
In the present study, we have not explored the role of ROS which are also prominently
involved in lung reperfusion injury. Although ROS could be linked with some of the
platelet-related responses that we have investigated, this issue is beyond the scope of this
investigation and was not addressed. Increased platelet-endothelium interactions may
result from endothelium dysfunction as well as platelet activation. Further studies are
needed to determine the contribution of endothelial and platelet P-selectin and other
adhesion molecules in this process. Although we found a correlation between platelet
adhesion and a decrease in arteriolar diameter, we have not determined the contribution
of the platelet adhesion to this process. Since during IR, RNS may also directly cause the
arteriolar constriction, and numerous other factors are involved in this process, further
elucidation of mechanisms of platelet involvement in pulmonary microcirculation need to
be done to take the next step in answering these important questions.
Our investigation shows that platelet-arteriolar wall adhesion with platelet
accumulation in the pulmonary microvasculature and arteriolar constriction are
significant factors in pulmonary ischemia, especially during the early phase of
reperfusion. Inhibition of platelet-arteriolar wall interactions could help to improve
alveolar perfusion in diseases associated with pulmonary ischemia-reperfusion injury.
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